Jean E. Merrill

Sanofi (United States)

Papers

1

Total Citations

68

H-Index

1

About

Jean E. Merrill is a distinguished neuroscientist whose research has fundamentally advanced our understanding of multiple sclerosis (MS) and the mechanisms of demyelination and remyelination. Her work bridges basic neuroimmunology and translational pharmacology, with a particular focus on how the immune system interacts with the central nervous system to drive disease progression. Merrill’s most-cited paper, "In Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination" (2008, 68 citations), provides a critical methodological framework for studying myelin repair—a cornerstone for developing therapies that could reverse damage in MS. Beyond this, her research has elucidated the roles of cytokines, microglia, and astrocytes in neuroinflammation, offering insights into potential therapeutic targets. With a career spanning decades, Merrill has not only contributed seminal findings but also mentored a generation of scientists. Her work remains highly influential, cited extensively in both preclinical and clinical studies, and continues to shape strategies for promoting remyelination and neuroprotection in demyelinating diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
68
Total Citations
68
Avg Citations/Paper
🏆 Most Cited Paper
In Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination
68 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 0
🏛 Institutions: Sanofi (United States)

Top Papers

  1. 1

Contact & Links

Available for collaboration
Content generated · 11 days ago